Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03404960 |
|---|---|
| Brief Title: | Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy (Parpvax) |
| First Submitted : | December 19, 2017 |
| First Submitted that Met QC Criteria : | January 12, 2018 |
| First Posted : | January 19, 2018 |
| Results First Submitted : | May 9, 2023 |
| Results First Posted with QC Comments : | June 5, 2023 |
| Results First Submitted that Met QC Criteria : | June 12, 2023 |
| Results First Posted : | July 3, 2023 |
| Certification/Extension First Submitted : | March 21, 2023 |
| Certification/Extension First Posted : | July 3, 2023 |
| Last Update Submitted that Met QC Criteria : | March 25, 2024 |
| Last Update Posted : | March 26, 2024 |